{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:34:03Z","timestamp":1744209243773,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,24]]},"DOI":"10.7759\/cureus.79578","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:57:17Z","timestamp":1740423437000},"source":"Crossref","is-referenced-by-count":1,"title":["Predictors of Mortality in Acute Myocardial Infarction Patients With Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Etuk","family":"Aniekeme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"De Souza Goncalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rueda Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al.. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020, 141:e139-596. 10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00966","article-title":"Noninvasive imaging of immune cell activity in myocardial infarction phases using (99m)Tc-HYNIC-mAb(Kv1.3) SPECT\/CT","volume":"22","author":"Wang Z","year":"2025","unstructured":"Wang Z, Song X, Cheng S, et al.. Noninvasive imaging of immune cell activity in myocardial infarction phases using (99m)Tc-HYNIC-mAb(Kv1.3) SPECT\/CT. Mol Pharm. 2025, 22:817-26. 10.1021\/acs.molpharmaceut.4c00966","journal-title":"Mol Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa486","article-title":"Has the fourth universal definition of myocardial infarction led to better diagnosis and risk stratification?","volume":"42","author":"Bueno H","year":"2021","unstructured":"Bueno H, Rossello X, Bardaj\u00ed A. Has the fourth universal definition of myocardial infarction led to better diagnosis and risk stratification?. Eur Heart J. 2021, 42:2562-4. 10.1093\/eurheartj\/ehaa486","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17051525","article-title":"The association between health insurance and all-cause, cardiovascular disease, cancer and cause-specific mortality: a prospective cohort study","volume":"17","author":"Song L","year":"2020","unstructured":"Song L, Wang Y, Chen B, Yang T, Zhang W, Wang Y. The association between health insurance and all-cause, cardiovascular disease, cancer and cause-specific mortality: a prospective cohort study. Int J Environ Res Public Health. 2020, 17:1525. 10.3390\/ijerph17051525","journal-title":"Int J Environ Res Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2023.69.3.28","article-title":"Transitioning to unfractionated heparin in treatment of non-ST-segment elevation myocardial infarction patients on direct oral anti-Xa inhibitors","volume":"69","author":"Mohamed Tashani","year":"2023","unstructured":"Mohamed Tashani, Raice A Stevens, Bruno de Souza Goncalves, et al.. Transitioning to unfractionated heparin in treatment of non-ST-segment elevation myocardial infarction patients on direct oral anti-Xa inhibitors. Cell Mol Biol. 2023, 69:191-7. 10.14715\/cmb\/2023.69.3.28","journal-title":"Cell Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/0115701611325234241202073459","article-title":"The immune system, an arrow to the heart and principles of cardioimmunology as an emerging branch of medicine","volume":"23","author":"Caiati C","year":"2025","unstructured":"Caiati C, Jirillo E. The immune system, an arrow to the heart and principles of cardioimmunology as an emerging branch of medicine. Curr Vasc Pharmacol. 2025, 23:162-171. 10.2174\/0115701611325234241202073459","journal-title":"Curr Vasc Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24356","article-title":"Mortality among hospitalized individuals with systemic lupus erythematosus in the US between 2006 and 2016","volume":"73","author":"Anastasiou C","year":"2021","unstructured":"Anastasiou C, Trupin L, Glidden DV, et al.. Mortality among hospitalized individuals with systemic lupus erythematosus in the US between 2006 and 2016. Arthritis Care Res (Hoboken). 2021, 73:1444-50. 10.1002\/acr.24356","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava A","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019, 96:1-13. 10.1016\/j.jaut.2018.11.001","journal-title":"J Autoimmun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319877947","article-title":"Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population","volume":"28","author":"Ingvarsson RF","year":"2019","unstructured":"Ingvarsson RF, Landgren AJ, Bengtsson AA, J\u00f6nsen A. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population. Lupus. 2019, 28:1488-94. 10.1177\/0961203319877947","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.98","article-title":"Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention","volume":"7","author":"McMahon M","year":"2011","unstructured":"McMahon M, Hahn BH, Skaggs BJ. Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Rev Clin Immunol. 2011, 7:227-41. 10.1586\/eci.10.98","journal-title":"Expert Rev Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.029","article-title":"Long-term cardiovascular outcomes in systemic lupus erythematosus","volume":"77","author":"Yafasova A","year":"2021","unstructured":"Yafasova A, Fosb\u00f8l EL, Schou M, et al.. Long-term cardiovascular outcomes in systemic lupus erythematosus. J Am Coll Cardiol. 2021, 77:1717-27. 10.1016\/j.jacc.2021.02.029","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/ar3759","article-title":"Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study","volume":"14","author":"Gustafsson JT","year":"2012","unstructured":"Gustafsson JT, Simard JF, Gunnarsson I, et al.. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther. 2012, 14:R46. 10.1186\/ar3759","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1452678","article-title":"Pathological mechanisms and crosstalk among various cell death pathways in cardiac involvement of systemic lupus erythematosus","volume":"15","author":"Wei J","year":"2024","unstructured":"Wei J, Wang A, Li B, et al.. Pathological mechanisms and crosstalk among various cell death pathways in cardiac involvement of systemic lupus erythematosus. Front Immunol. 2024, 15:1452678. 10.3389\/fimmu.2024.1452678","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus--an update","volume":"24","author":"Choi J","year":"2012","unstructured":"Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus--an update. Curr Opin Immunol. 2012, 24:651-7. 10.1016\/j.coi.2012.10.004","journal-title":"Curr Opin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou I","year":"2019","unstructured":"Andreadou I, Cabrera-Fuentes HA, Devaux Y, et al.. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019, 115:1117-30. 10.1093\/cvr\/cvz050","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000226","article-title":"Macrophage migration inhibitory factor for the early prediction of infarct size","volume":"2","author":"Chan W","year":"2013","unstructured":"Chan W, White DA, Wang XY, et al.. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc. 2013, 2:e000226. 10.1161\/JAHA.113.000226","journal-title":"J Am Heart Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet C","year":"2020","unstructured":"Peet C, Ivetic A, Bromage DI, Shah AM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020, 116:1101-12. 10.1093\/cvr\/cvz336","journal-title":"Cardiovasc Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20160005","article-title":"Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment","volume":"106","author":"Azevedo PS","year":"2016","unstructured":"Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016, 106:62-9. 10.5935\/abc.20160005","journal-title":"Arq Bras Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06539-2","article-title":"Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus","volume":"42","author":"Huang S","year":"2023","unstructured":"Huang S, Zhang Z, Cui Y, Yao G, Ma X, Zhang H. Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus. Clin Rheumatol. 2023, 42:1565-72. 10.1007\/s10067-023-06539-2","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00922-y","article-title":"Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus","volume":"44","author":"Oliveira CB","year":"2022","unstructured":"Oliveira CB, Kaplan MJ. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus. Semin Immunopathol. 2022, 44:309-24. 10.1007\/s00281-022-00922-y","journal-title":"Semin Immunopathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2021.0320","article-title":"Global awareness of myocardial infarction symptoms in general population","volume":"51","author":"Kim SJ","year":"2021","unstructured":"Kim SJ. Global awareness of myocardial infarction symptoms in general population. Korean Circ J. 2021, 51:997-1000. 10.4070\/kcj.2021.0320","journal-title":"Korean Circ J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan M","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022, 80:2361-71. 10.1016\/j.jacc.2022.11.005","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191187","article-title":"Healthcare utilization and costs of systemic lupus erythematosus by disease severity in the United States","volume":"48","author":"Murimi-Worstell IB","year":"2021","unstructured":"Murimi-Worstell IB, Lin DH, Kan H, et al.. Healthcare utilization and costs of systemic lupus erythematosus by disease severity in the United States. J Rheumatol. 2021, 48:385-93. 10.3899\/jrheum.191187","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.02.004","article-title":"Estimating the economic burden of acute myocardial infarction in the US: 12 year national data","volume":"359","author":"Bishu KG","year":"2020","unstructured":"Bishu KG, Lekoubou A, Kirkland E, et al.. Estimating the economic burden of acute myocardial infarction in the US: 12 year national data. Am J Med Sci. 2020, 359:257-65. 10.1016\/j.amjms.2020.02.004","journal-title":"Am J Med Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101086","article-title":"Clinical outcomes of acute myocardial infarction hospitalizations with systemic lupus erythematosus: an analysis of nationwide readmissions database","volume":"47","author":"Sagheer S","year":"2022","unstructured":"Sagheer S, Deka P, Pathak D, et al.. Clinical outcomes of acute myocardial infarction hospitalizations with systemic lupus erythematosus: an analysis of nationwide readmissions database. Curr Probl Cardiol. 2022, 47:101086. 10.1016\/j.cpcardiol.2021.101086","journal-title":"Curr Probl Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/art.27551","article-title":"Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus","volume":"62","author":"Scalzi LV","year":"2010","unstructured":"Scalzi LV, Hollenbeak CS, Wang L. Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus. Arthritis Rheum. 2010, 62:2767-75. 10.1002\/art.27551","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33449","article-title":"Coronary artery disease in systemic lupus erythematosus: what do the facts say?","volume":"15","author":"Melano-Carranza E","year":"2023","unstructured":"Melano-Carranza E, Zambrano-Zambrano A, Valle-Uitzil W, et al.. Coronary artery disease in systemic lupus erythematosus: what do the facts say?. Cureus. 2023, 15:e33449. 10.7759\/cureus.33449","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2021.09.004","article-title":"Impact of menopause on women with systemic lupus erythematosus","volume":"154","author":"Karvonen-Gutierrez CA","year":"2021","unstructured":"Karvonen-Gutierrez CA, Leis A. Impact of menopause on women with systemic lupus erythematosus. Maturitas. 2021, 154:25-30. 10.1016\/j.maturitas.2021.09.004","journal-title":"Maturitas"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew399","article-title":"The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus","volume":"56","author":"Lewis MJ","year":"2017","unstructured":"Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford). 2017, 56:i67-77. 10.1093\/rheumatology\/kew399","journal-title":"Rheumatology (Oxford)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002154","article-title":"Racial differences in arterial stiffness and microcirculatory function between Black and White Americans","volume":"2","author":"Morris AA","year":"2013","unstructured":"Morris AA, Patel RS, Binongo JN, et al.. Racial differences in arterial stiffness and microcirculatory function between Black and White Americans. J Am Heart Assoc. 2013, 2:e002154. 10.1161\/JAHA.112.002154","journal-title":"J Am Heart Assoc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2016.10.011","article-title":"Race-related differences in left\u00a0ventricular structural and functional\u00a0remodeling in response\u00a0to\u00a0increased afterload: The ARIC Study","volume":"5","author":"Fernandes-Silva MM","year":"2017","unstructured":"Fernandes-Silva MM, Shah AM, Hegde S, et al.. Race-related differences in left\u00a0ventricular structural and functional\u00a0remodeling in response\u00a0to\u00a0increased afterload: The ARIC Study. JACC Heart Fail. 2017, 5:157-65. 10.1016\/j.jchf.2016.10.011","journal-title":"JACC Heart Fail"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.09.090","article-title":"Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality","volume":"101","author":"Berger AK","year":"2008","unstructured":"Berger AK, Duval S, Jacobs DR Jr, Barber C, Vazquez G, Lee S, Luepker RV. Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality. Am J Cardiol. 2008, 101:428-34. 10.1016\/j.amjcard.2007.09.090","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/339100-predictors-of-mortality-in-acute-myocardial-infarction-patients-with-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:57:26Z","timestamp":1740423446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/339100-predictors-of-mortality-in-acute-myocardial-infarction-patients-with-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.79578","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}